Miller Value Partners, LLC / TEVA
Miller Value Partners, LLC’s Teva Pharmaceutical Inds Ltd Position
Does Miller Value Partners, LLC own Teva Pharmaceutical Inds Ltd (TEVA)? Not currently — the last reported position was 10.9K shares worth $241,338 in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$241,338
Q4 2024
Shares
10.9K
% of Portfolio
+0.10%
Quarters Held
25
position exited
Position History TEVA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2024 | 10.9K | $241,338 | +0.10% |
| Q3 2024 | 10.9K | $197,319 | +0.11% |
| Q2 2024 | 10.9K | $177,937 | +0.11% |
| Q1 2024 | 11.6K | $163,676 | +0.10% |
| Q4 2023 | 13.4K | $139,896 | +0.08% |
| Q3 2023 | 14.2K | $145,095 | +0.09% |
| Q2 2023 | 82.1K | $618,492 | +0.41% |
| Q1 2023 | 3.93M | $35M | +2.17% |
| Q4 2022 | 5.15M | $47M | +3.03% |
| Q3 2022 | 9.25M | $75M | +4.54% |
| Q2 2022 | 9.33M | $70M | +3.57% |
| Q1 2022 | 10.06M | $94M | +3.04% |
| Q4 2021 | 9.66M | $77M | +2.12% |
| Q3 2021 | 9.75M | $95M | +2.20% |
| Q2 2021 | 10.94M | $108M | +2.58% |
| Q1 2021 | 10.55M | $122M | +3.15% |
| Q4 2020 | 7.14M | $69M | +2.10% |
| Q3 2020 | 8.09M | $73M | +2.62% |
| Q2 2020 | 7.85M | $97M | +4.30% |
| Q1 2020 | 7.92M | $71M | +4.57% |
| Q4 2019 | 9.83M | $96M | +3.42% |
| Q3 2019 | 8.49M | $58M | +2.35% |
| Q2 2019 | 6.50M | $60M | +2.28% |
| Q1 2019 | 4.54M | $71M | +2.82% |
| Q4 2018 | 3.91M | $60M | +2.74% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Miller Value Partners, LLC’s full portfolio or all institutional holders of TEVA.